{
  "catalogId": "f7843e2c-bd86-43a4-af2f-5a73a1fd9a96",
  "name": "BENLYSTA I.V. 120 MG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "147 37 33499 00",
  "treatmentDescriptions": "Benlysta is indicated as add-on therapy in patients aged 5 years and older with active, autoantibody-positive systemic lupus erythematosus (SLE) with a high degree of disease activity (e.g., positive anti-dsDNA and low complement) despite standard therapy.Benlysta is indicated in combination with background immunosuppressive therapies for the treatment of adult patients with active lupus nephritis.",
  "termsOfIssue": "Prescription required",
  "form": "powder for concentrate for solution for infusion",
  "route": "i.v",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "BELIMUMAB",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L04AA26",
      "name": "BELIMUMAB"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "BENLYSTA 200 MG 4 PREFILLED SYR",
      "manufacturer": {
        "name": "ג.ס.ק",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 4.0,
        "unit": "units"
      },
      "packagingDescription": "VIAL GLASS TYPE I",
      "shelfLife": "60",
      "storageConditions": "",
      "codes": {
        "moh": "8337",
        "yarpa": "26816",
        "pharmasoft": "2647",
        "barcode": "7290010140893"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 3331.527,
        "retailMargin": 10.0,
        "maxRetailPrice": 3664.6797,
        "maxPriceWithVAT": 4324.321854
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-07-31T22:09:13.851062"
  }
}